Notice: This company has been marked as potentially delisted and may not be actively trading. BioDelivery Sciences International (BDSI) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Florida International UniversitySeptember 14, 2023 | usnews.comInternational High School for Health SciencesMay 6, 2023 | usnews.comInternational climate change bodies win humanity awardOctober 15, 2022 | omaha.comPerilous Reversal Watch: BioDelivery Sciences International (BDSI)September 16, 2022 | thestreet.comScienceSeptember 13, 2022 | npr.orgCollegium Pharmaceutical, Inc. (COLL) CEO Joe Ciaffoni on Q1 2022 Results - Earnings Call TranscriptMay 10, 2022 | seekingalpha.comJim Cramer's Top Stock Picks: DF MNST BDSIMay 2, 2022 | thestreet.comWhy Collegium Pharmaceutical's Shares Are Trading Higher TodayApril 5, 2022 | benzinga.comBioDelivery Sciences International (NASDAQ:BDSI) Rating Lowered to Hold at StockNews.comStockNews.com downgraded BioDelivery Sciences International from a "buy" rating to a "hold" rating in a research report on Thursday.March 24, 2022 | marketbeat.comBioDelivery Sciences International (NASDAQ:BDSI) Lowered to "Hold" at Truist FinancialTruist Financial cut BioDelivery Sciences International from a "buy" rating to a "hold" rating in a research report on Friday.February 25, 2022 | marketbeat.comCardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue EstimatesFebruary 24, 2022 | finance.yahoo.comBioDelivery Sciences launches migraine therapy in U.S.February 24, 2022 | seekingalpha.comBioDelivery Sciences International (BDSI) Just Flashed Golden Cross Signal: Do You Buy?February 24, 2022 | finance.yahoo.comBioDelivery Sciences International (NASDAQ:BDSI) Lowered to Hold at Cantor FitzgeraldCantor Fitzgerald lowered BioDelivery Sciences International to a "hold" rating and set a $5.60 price target for the company. in a research report on Friday.February 19, 2022 | marketbeat.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of BioDelivery Sciences International, Inc. BuyoutFebruary 15, 2022 | stockhouse.comBDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of BioDelivery Sciences International, Inc. Is Fair to ShareholdersFebruary 14, 2022 | apnews.comBDSI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of BioDelivery Sciences International, Inc. Is Fair to ShareholdersFebruary 14, 2022 | apnews.comBioDelivery's stock rockets toward a 2-year high after buyout deal with Collegium at a 54% premiumFebruary 14, 2022 | finance.yahoo.comWhy the Earnings Surprise Streak Could Continue for BioDelivery (BDSI)February 7, 2022 | finance.yahoo.comBioDelivery Sciences International (NASDAQ:BDSI) Could Easily Take On More DebtFebruary 6, 2022 | nasdaq.comShould Value Investors Pick BioDelivery (BDSI) Stock Now?January 31, 2022 | finance.yahoo.comBioDelivery Sciences International (NASDAQ:BDSI) Price Target Increased to $4.50 by Analysts at HC WainwrightHC Wainwright boosted their price target on shares of BioDelivery Sciences International from $4.00 to $4.50 and gave the stock a "neutral" rating in a report on Friday.January 21, 2022 | marketbeat.comBioDelivery Sciences International Target of Unusually High Options Trading (NASDAQ:BDSI)BioDelivery Sciences International, Inc. (NASDAQ:BDSI) was the target of some unusual options trading activity on Friday. Stock investors purchased 3,295 call options on the stock. This represents an increase of 224% compared to the typical volume of 1,018 call options.December 31, 2021 | marketbeat.comRaleigh pharma gets favorable ruling in case for drug exclusivityDecember 28, 2021 | finance.yahoo.comWhy BioDelivery Sciences International Stock Was Up 28.5% MondayDecember 20, 2021 | fool.comWhy Is BioDelivery (BDSI) Down 20.8% Since Last Earnings Report?December 3, 2021 | finance.yahoo.comBioDelivery Sciences International, Inc. (BDSI)November 17, 2021 | finance.yahoo.comBiodelivery Sciences Intl Insider Makes $320K Stock PurchaseNovember 15, 2021 | finance.yahoo.comTuesday 11/9 Insider Buying Report: BDSI, BALYNovember 9, 2021 | nasdaq.comBioDelivery Sciences International (BDSI) Tops Q3 Earnings EstimatesNovember 3, 2021 | finance.yahoo.comAnalysts Estimate BioDelivery Sciences International (BDSI) to Report a Decline in Earnings: What to Look Out forOctober 27, 2021 | msn.comBioDelivery Sciences Appoints John Golubieski as Chief Financial OfficerOctober 21, 2021 | finance.yahoo.comBioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021October 20, 2021 | finance.yahoo.comHere's Why We Think BioDelivery Sciences International (NASDAQ:BDSI) Is Well Worth WatchingOctober 3, 2021 | finance.yahoo.comBioDelivery Sciences International to Host ELYXYB™ Investor DaySeptember 30, 2021 | feeds.benzinga.comBioDelivery Sciences International slips after revenue outlook disappointsSeptember 22, 2021 | seekingalpha.comBioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the ...September 8, 2021 | apnews.comBioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 ConferenceSeptember 7, 2021 | finance.yahoo.comMarket Cool On BioDelivery Sciences International, Inc.'s (NASDAQ:BDSI) EarningsSeptember 3, 2021 | finance.yahoo.comBioDelivery Sciences to Participate in Upcoming Virtual Investor ConferencesSeptember 3, 2021 | finance.yahoo.comAzurRx BioPharma Announces Appointment of Terry Coelho to its Board of DirectorsAugust 16, 2021 | finance.yahoo.comNot Many Are Piling Into BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Just YetAugust 6, 2021 | nasdaq.comBioDelivery Sciences Announces Agreement to Acquire U.S. and Canadian Rights to FDA-approved ELYXYB(TM) for the Acute Treatment of MigraineAugust 5, 2021 | marketwatch.comBioDelivery Sciences International, inc (BDSI) Q2 2021 Earnings Call TranscriptAugust 4, 2021 | fool.comBioDelivery Sciences Reports Mixed Q2 Earnings, Sees FY21 Belbuca Sales At Lower End Of Guidance RangeAugust 4, 2021 | markets.businessinsider.comDr. Reddy’s Laboratories Announces Entry Into Definitive Agreement with BioDelivery Sciences International, Inc., to Sell its U.S. and Canada Territory Rights for ELYXYB ...August 4, 2021 | businesswire.comBioDelivery Sciences Reports Second Quarter 2021 ResultsAugust 4, 2021 | finance.yahoo.comBioDelivery Sciences International, Inc. 2021 Q2 - Results - Earnings Call PresentationAugust 4, 2021 | seekingalpha.comBRIEF-BioDelivery Sciences Reports Second Quarter 2021 ResultsAugust 4, 2021 | msn.comHere's what Wall Street expects from Biodelivery Sciences International's earningsAugust 2, 2021 | markets.businessinsider.com Get BioDelivery Sciences International News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Financial Prophecy (Ad)The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier. Including the name of the #1 company to buy. BDSI Media Mentions By Week BDSI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BDSI News Sentiment▼0.000.49▲Average Medical News Sentiment BDSI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BDSI Articles This Week▼00▲BDSI Articles Average Week Get BioDelivery Sciences International News Delivered to You Automatically Sign up to receive the latest news and ratings for BDSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Immunic News Ovid Therapeutics News TherapeuticsMD News Supernus Pharmaceuticals News Pacira BioSciences News Omeros News Nektar Therapeutics News Assembly Biosciences News Cumberland Pharmaceuticals News Xenon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BDSI) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioDelivery Sciences International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioDelivery Sciences International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BDSI Stock Alerts